We are live on
!
Find out more
LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$2.63B
1-Year Est. Return
31.52%
This Fund
S&P 500
This Quarter
Est. Return
+3.57%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$984M
AUM Growth
-$1.14M
(-0.12%)
Cap. Flow
-$27.8M
Cap. Flow
% of AUM
-2.83%
Top 10 Holdings %
Top 10 Hldgs %
25.61%
Holding
404
New
43
Increased
110
Reduced
106
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$12.3M |
| 2 |
Apollo Global Management
APO
|
+$11.4M |
| 3 |
Halozyme
HALO
|
+$8.87M |
| 4 |
Las Vegas Sands
LVS
|
+$8.8M |
| 5 |
Lowe's Companies
LOW
|
+$8.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$21.9M |
| 2 |
Pricesmart
PSMT
|
+$11.5M |
| 3 |
DESP
Despegar.com
DESP
|
+$10.4M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$8.95M |
| 5 |
West Pharmaceutical
WST
|
+$7.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.37% |
| 2 | Consumer Discretionary | 18.24% |
| 3 | Consumer Staples | 9.52% |
| 4 | Financials | 8.75% |
| 5 | Industrials | 5.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
HCA Healthcare
HCA
$89.8B
| $219K | 0.02% |
1,617
| – | – |
|
302
DTE Energy
DTE
$28.9B
| $218K | 0.02% |
2,006
| – | – |
|
303
Dollar Tree
DLTR
$24.7B
| $217K | 0.02% |
2,021
| – | – |
|
304
Open Text
OTEX
$5.8B
| $215K | 0.02% |
+3,980
| New | +$158K |
|
305
ConocoPhillips
COP
$153B
| $214K | 0.02% |
3,513
-529
| -13% | -$32.9K |
|
306
US Bancorp
USB
$101B
| $212K | 0.02% |
+4,040
| New | +$208K |
|
307
Canadian Imperial Bank of Commerce
CM
$110B
| $210K | 0.02% |
+4,070
| New | +$164K |
|
308
Willis Towers Watson
WTW
$31.6B
| $208K | 0.02% |
+1,085
| New | +$196K |
|
309
Sysco
SYY
$40.5B
| $207K | 0.02% |
2,934
-2,703
| -48% | -$192K |
|
310
Analog Devices
ADI
$187B
| $205K | 0.02% |
+1,819
| New | +$197K |
|
311
Cognizant
CTSH
$26.2B
| $204K | 0.02% |
+3,212
| New | +$211K |
|
312
Nutrien
NTR
$32.1B
| $201K | 0.02% |
+2,866
| New | +$150K |
|
313
Teva Pharmaceuticals
TEVA
$42.8B
| $158K | 0.02% |
17,069
| – | – |
|
314
Regions Financial
RF
$26.9B
| $150K | 0.02% |
10,068
| – | – |
|
315
BlackBerry
BB
$5.14B
| $130K | 0.01% |
+13,273
| New | +$115K |
|
316
Alexandria Real Estate Equities
ARE
$8.27B
| – | – |
-1,792
| Closed | -$255K |
|
317
Becton Dickinson
BDX
$50B
| – | – |
-17,069
| Closed | -$4.16M |
|
|
BNY
318
Bank of New York Mellon
BNY
$111B
| – | – |
-22,896
| Closed | -$1.16M |
|
319
Baker Hughes
BKR
$63.8B
| – | – |
-15,816
| Closed | -$438K |
|
320
CALL
Berkshire Hathaway Class B
BRK.B
$1.09T
| – | – |
-1,300
| Closed | -$261K |
|
321
Boston Properties
BXP
$10.8B
| – | – |
-4,352
| Closed | -$583K |
|
322
Citigroup
C
$231B
| – | – |
-10,991
| Closed | -$684K |
|
323
Crown Castle
CCI
$31.5B
| – | – |
-10,737
| Closed | -$1.37M |
|
324
CenterPoint Energy
CNP
$26.7B
| – | – |
-7,150
| Closed | -$220K |
|
325
Capital One
COF
$136B
| – | – |
-4,748
| Closed | -$388K |
|
Similar funds
SI
WWM
ACM
CCM
MG
PCMI
PCIG
MAMU
Lombard Odier Asset Management (Switzerland)'s Q2 2019 Portfolio in Review
As of Q2 2019, Lombard Odier Asset Management (Switzerland) held 404 positions worth $984M, down 0.12% from $986M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Lombard Odier Asset Management (Switzerland)'s Q2 2019 filing shows 43 new, 110 increased, 106 reduced and 68 closed positions. Its largest new stake was Apollo Global Management: 360,000 shares worth $12.3M. The largest sale was Pfizer, an estimated $21.9M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Lombard Odier Asset Management (Switzerland)'s largest Q2 2019 buy was Apollo Global Management: 360,000 shares worth $12.3M.
- Lombard Odier Asset Management (Switzerland) added most to Boston Scientific in Q2 2019, an estimated $12.3M increase.
- Lombard Odier Asset Management (Switzerland)'s biggest Q2 2019 reduction was Pfizer, cutting an estimated $21.9M.
- Lombard Odier Asset Management (Switzerland) fully exited Despegar.com in Q2 2019, selling an estimated $10.4M.
- Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 26% of its $984M portfolio in Q2 2019.
- Lombard Odier Asset Management (Switzerland) opened 43 new positions and closed 68 in Q2 2019.
- Lombard Odier Asset Management (Switzerland)'s portfolio value fell 0.12% quarter-over-quarter to $984M.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2019, filed 14 Aug 2019.